← All trials
NCT07185594
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 24, 2025
- Primary completion
- Dec 31, 2025
- Completion date
- Jan 31, 2026
- First posted
- Sep 22, 2025
- Last posted
- Nov 17, 2025
- Enrollment
- 360
- Arms / groups
- 5 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.Lead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.